Paravertebral block with modified catheter under surgeon's direct vision after video-assisted thoracoscopic lobectomy.

BACKGROUND: Paravertebral block (PVB) conducted by epidural catheter is a prevalent pain management for patients undergoing video-assisted thoracoscopic surgery (VATS) lobectomy. The aim of this study was to assess the efficacy and safety of paravertebral block with a modified PVB (MPVB) catheter under surgeon's direct vision after video-assisted thoracoscopic lobectomy.
METHODS: Three hundred fifty-six patients undergoing VATS lobectomy were retrospectively reviewed and divided into two groups consecutively according to the catheter applied in PVB procedure (PVB group and MPVB group). In the MPVB group, a modified catheter with a flexible forepart and more apertures distributing along the forepart than the conventional epidural catheter was introduced. An infusion pump containing of 150 mL mixture was connected to the catheter to provide sustained regional analgesia. Intramuscular dezocine 10 mg was administered as a rescue medication when necessary. Postoperative pain management effect was assessed by visual analog scale (VAS) at rest and on coughing. Spirometry values and blood gas analysis were monitored and recorded for the first 3 postoperative days (PODs). Analgesia-related adverse events, characteristics of PVB procedure and postoperative major complication were also compared between the two groups.
RESULTS: There were 172 patients who received PVB with conventional epidural catheter in the PVB group, and 184 patients were performed PVB with modified paravertebral catheter in the MPVB group. Significantly lower pain score at rest was found in MPVB group at 24 h postoperatively (P=0.006). The pain score on coughing in MPVB group was significantly lower than that in PVB group at 12 and 24 h postoperatively (P=0.037 and P<0.001, respectively). Patients needing for rescue medication was significantly lower in the MPVB group (P=0.028). The incidence of pleural perforation was lower in the MPVB group (P=0.020). Postoperative spirometry values revealed comparable pulmonary function between the two groups, and arterial blood gas analysis showed a normal range of pH and PaCO2 in both groups. There was no significant difference of analgesia-related adverse events as well as major complications between the two groups.
CONCLUSIONS: PVB with modified catheter under surgeon's direct vision was effective and safe after video-assisted thoracoscopic lobectomy. 2020 Journal of Thoracic Disease. All rights reserved.

Introduction

Video-assisted thoracoscopic surgery (VATS) was introduced to replace open thoracic surgery in high-volume experienced centers due to its several superiorities, including fewer postoperative complications, better preservation of respiratory function and shorter postoperative hospital stay (1-3). However, the moderate-to-severe postoperative pain was found in patients who benefit from VATS on account of the ports and chest drains, and the extent of surgery (4). Therefore, analgesia remains an important consideration after VATS lobectomy.

Numerous pain management options for VATS have been reported in the recent studies, including non-steroidal anti-inflammatory drugs (NSAIDs), thoracic epidural analgesia (TEA), systemic opioids and paravertebral block (PVB) (5-7). Over the years, TEA has been considered the golden standard of analgesia for thoracic surgery (8). Recently, multiple meta-analyses revealed that PVB can provide comparable pain relief to TEA with less frequent adverse reactions after thoracic surgery (9,10). Besides, continuous paravertebral block was indicated as equally effective as epidural block for pain management after VATS lobectomy, and might have a better profile of safety than epidural block (11). However, the procedure and device of PVB for thoracoscopic surgery has not been well established (12). Despite the methods of ultrasound-guide that can be applied, PVB using the classical landmark puncture technique is still considered not satisfactorily predictable (13-15). Recently, the method of catheter insertion into the paravertebral space which could be verified continuously by the surgeon using the camera is preferable in some centers (11,16). Furthermore, no gold standard for PVB device has been introduced for patients undergoing VATS so far, especially for the paravertebral catheter. Currently, the conventional epidural catheter was still applied in PVB procedure in several researches.

A modified PVB (MPVB) catheter which was placed in the paravertebral space under thoracoscopic guidance by the surgeons has been employed for patients undergoing VATS lobectomy in our institution since 2017. The aim of this study was to explore whether the modified PVB catheter has any advantages over the conventional epidural catheter used for PVB in pain management after VATS lobectomy. We present the following article in accordance with the STROBE Guideline (available at http://dx.doi.org/10.21037/jtd-20-1068B).

Methods

Patients

In order to minimize selection bias, we retrospectively reviewed the database of consecutive 356 patients who underwent VATS lobectomy and extended lymphadenectomy with PVB by a single surgical team (YS) from July 2015 to December 2018 at our department. All patients were evaluated suitable for VATS preoperatively and no intraoperative conversion to open thoracotomy was happened in these 356 patients. The exclusion criteria were listed as followings: the American Society of Anesthesiologists (ASA) physical status classification greater than 3; chronic analgesic use or preexisting chronic pain syndromes; presence of chest surgery history or kyphoscoliosis; and patient records lacked sufficient information for analysis. Before March 2017, PVB was conducted with the conventional epidural catheter at our department. After that, the modified paravertebral catheter was applied for PVB in patients undergoing VATS lobectomy. The 356 patients were divided into two groups according to the catheter applied in PVB procedure (PVB group and MPVB group). Both groups had the same management and patient selection protocols. Uniportal VATS was tried to accomplish all of the operation first. If there was severe adhesion in the chest cavity or the operation from one port was hard, multi ports would be added to assist in completing the operation. The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013) and the Harmonized Tripartite Guideline for Good Clinical Practice from the International Conference on Harmonization. This study was reviewed and approved by the Institutional Review Board of the Jingling Hospital (approval number 2015NZKY-028-03). All patients enrolled completed the informed consent form. Age, gender, ASA classification, type of VATS (multi-portal or uni-portal VATS), number of harvested lymph nodes and TNM stage were recorded. Patient were instructed in how to assess their pain using a visual analog scale (VAS) of 0–10 cm (0 cm: no pain, 10 cm: worst pain imaginable) after surgery.

Procedure of anesthesia and VATS lobectomy

Noninvasive blood pressure (NIBP), electrocardiography, and pulse oximetry were monitored, after which an intravenous saline infusion (10 mL/kg/h) was started. Meanwhile, general anesthesia and resuscitation were kept ready. General anesthesia was induced with 2.0 mg/kg of propofol, 2.0 µg/kg of fentanyl, and 1.0 mg/kg of rocuronium. A double-lumen endotracheal tube was placed and appropriate position confirmed. Anesthesia was maintained with continuous infusion of propofol at the rate of 8–12 mg/kg/h, with 2 µg/kg of fentanyl and 0.15 mg/kg of rocuronium bolused every 30 minutes. Then, surgery was performed with one-lung ventilation. Lobectomy resection with radical lymphadenectomy were performed in all the patients in this study.

Technique of postoperative analgesia

In the two groups, conventional epidural catheter and modified paravertebral catheter were both placed under sterile conditions upon completion of surgery. The percutaneous puncture point, which is equidistant to the upper and lower intercostal space, was marked 2–3 cm lateral to the midline. A 22-gauge Tuohy needle was advanced perpendicularly through the chest wall until the needle tip was visible in both groups. Then a conventional epidural catheter (B/Braun, Melsungen, Germany) was passed through the needle into the paravertebral space in the PVB group, while a modified paravertebral catheter (Fullcare, Beijing, China) was applied in the MPVB group. The tip of the modified paravertebral catheter was hemispherical with several pores and the 6 cm flexible forepart of the modified catheter had more apertures distributing tightly than the conventional epidural catheter (). After injection of 20 mL saline created an extrapleural detachment pocket (), the modified catheter was inserted approximately 6 cm into the paravertebral space under direct visual control by the surgeon who confirmed its correct location. If pleural perforation or hematoma under parietal pleura happened during the process, another alternative insertion point would be selected. After catheter placement, an initial dose of 0.3 mL/kg of 0.2% ropivacaine, 0.05% bupivacaine and 0.26% lidocaine hydrochloride were infused into the paravertebral space through the catheter. Then an 150 mL infusion pump containing of the same ropivacaine, bupivacaine and lidocaine hydrochloride mixture was connected to the catheter to provide a continuous infusion after surgery (). The infusion rate of the mixture into the paravertebral space could be approximately 2 mL/h if the channel was absolutely unobstructed.

Figure 1

The modified paravertebral catheter which had hemispherical tip with several pores, 6-cm flexible forepart and several apertures distributing along the forepart (1 cm apart from each other).

Video 1

Extrapleural detachment pocket was created by saline injection under surgeon's direct vision.

Figure 2

Continuous paravertebral blockade.

Postoperative care

Patients were transferred to the intensive care unit of our department after replacing the double lumen tube to single lumen tube and extubated after completely waking up. If patients reported a VAS score >4 postoperatively, intramuscular dezocine 10 mg (Jiangsu, China) was administered as a rescue medication. The chest tube was removed when there was no leakage and the volume of drainage was less than 200 mL/24 hours, while the paravertebral catheter was also removed. The paravertebral catheter would be removed on post-operative day (POD) 3 with drainage required for more than three days after surgery. After removing chest drainage tubes, pain management was remained with 500 mg paracetamol oral route every 6 hours if VAS score over 4. The criteria for hospital discharge included pain controlled by oral analgesics, chest tube removal and assessment of patients’ well-being by attending doctors.

Clinical outcomes

The following outcomes were assessed: (I) the effect of postoperative pain management including VAS scores at the 2nd, 6th, 12th, 24th and 48th postoperative hours (at the state of rest/coughing) and the number of patients who required rescue medication before removing the pump; (II) respiratory function including spirometry values and blood gas analysis on postoperative days (PODs); (III) adverse events related to the analgesia, including respiratory depression (respiratory rate <8 breaths/min), nausea, vomiting, urinary retention, hypotension and headache; (IV) characteristics of PVB procedure, including pleural perforation and hematoma under parietal pleura as well as the consumption of drugs in the PVB pump; and (V) postoperative data including chest tube indwelling time, length of postoperative hospital stay and major complications. Hypotension was defined as systolic arterial pressure below 90 mmHg and/or systolic arterial pressure decrease by >20% compared with the pre-surgical value.

Statistical analysis

IBM SPSS for Windows, Version 22.0 (IBM Corporation, Armonk, NY, USA) was used for all statistical evaluations. Continuous variables were expressed as mean ± SD and were compared using independent samples Student’s t-test or Mann-Whitney U test. Categorical variables were summarized as proportions or percentages and were compared using χ2 test. P values less than 0.05 were considered statistically significant.

Results

There were 172 patients who received PVB with conventional epidural catheter (PVB group), and the other 184 patients were performed PVB with modified paravertebral catheter (MPVB group). The clinical characteristics of the PVB group and MPVB group are presented in . There were no significant differences between the two groups in terms of gender, age, ASA classification, preoperative comorbidities and pathologic stage (P>0.05).

Table 1

Baseline characteristics of patients in both groups

Variables	MPVB (n=182)	PVB (n=174)	P value
Age (years)	59.36±8.02	60.12±9.23	0.407
Gender			0.167
Male	85 (46.7%)	94 (54.0%)
Female	97 (53.3%)	80 (46.0%)
ASA classification			0.884
1	18 (9.9%)	20 (11.5%)
2	139 (76.4%)	131 (75.3%)
3	25 (13.7%)	23 (13.2%)
Hypertension	42 (23.1%)	36 (20.7%)	0.610
Diabetes	22 (12.1%)	17 (9.8%)	0.484
COPD	10 (5.5%)	11 (6.3%)	0.740
Histologic			0.339
Squamous cell carcinoma	43 (23.6%)	50 (28.7%)
Adenocarcinoma	129 (70.9%)	118 (67.8%)
Others	10 (5.5%)	6 (3.4%)
Type of VATS			0.113
Multi-portal VATS	112 (61.5%)	121 (69.5%)
Uni-portal VATS	70 (38.5%)	53 (30.5%)
Number of harvested lymph nodes	21.12±6.54	20.46±6.25	0.331
Pathologic stage			0.750
IA	23 (12.6%)	29 (16.7%)
IB	28 (15.4%)	27 (15.5%)
IIA	43 (23.6%)	32 (18.4%)
IIB	52 (28.6%)	49 (28.2%)
IIIA	25 (13.7%)	23 (13.2%)
IIIB	11 (6.0%)	14 (8.0%)

Data are presented as mean ± SD or n (%). PVB, paravertebral block using conventional epidural catheter; MPVB, paravertebral block using modified PVB catheter; ASA, American Society of Anesthesiologists; COPD, chronic obstructive pulmonary disease.

Postoperative pain scores at rest were compared at 2, 6, 12, 24, 48 and 72 hours. Significant lower pain score was found in MPVB group than that in PVB group at 24 h postoperatively (P=0.006; ). Pain scores on coughing were also compared at 2, 6, 12, 24, 48 and 72 hours. The pain scores in MPVB group were significantly lower than that in PVB group at 12 and 24 h postoperatively (P=0.037 and P<0.001, respectively; ). The number of patients who need for rescue medication via intramuscular dezocine before the infusion pump removed was significantly lower in MPVB group (10 in MPVB group versus 21 in PVB group) (P=0.028).

Figure 3

The average VAS scores of both groups during rest states were recorded. Significant differences were observed at 24 h after surgery between the two groups (**, P<0.01). The error bars represent SDs.

Figure 4

The average VAS scores of both groups during coughing states were recorded. Significant differences were observed at 12 and 24 h after surgery between the two groups (*, P<0.05, ***, P<0.001). The error bars represent SDs.

There was no significant difference of postoperative FVC and FEV1 between the two groups (). Arterial blood gas analysis demonstrated normal range of both pH and PaCO2 levels in two groups on PODs (). As shown in , no patients in either group suffered respiratory depression. There was no significant difference in other analgesia-related adverse events such as nausea and vomiting, hypotension, urinary retention and headache between the two groups. Moreover, the incidence of major complications—i.e., pneumonia, atelectasis, chylothorax, pulmonary embolism and reoperation—were comparable in both groups. In terms of the data related to PVB procedure, pleural perforation was observed in four and thirteen patients in the MPVB and PVB groups, respectively (2.2% vs. 7.5%, P=0.020), and hematoma under the parietal pleura occurred in six and eleven patients in the MPVB and PVB groups, respectively (3.3% vs. 6.3%, P=0.181). Upon the time of infusion pump removed, the consumption of analgesic drugs was significant lower in the PVB group (P=0.015). No cases of 30-day mortality were identified in all patients.

Table 2

FVC and FEV1 parameters in both groups

Parameters (time)	FVC (L)				FEV1 (L)
	MPVB (n=182)	PVB (n=174)	P value		MPVB (n=182)	PVB (n=174)	P value
Pre-operation	2.72±0.54	2.77±0.60	0.408		2.28±0.63	2.37±0.57	0.159
POD1	1.29±0.47	1.23±0.53	0.258		0.93±0.32	0.91±0.24	0.506
POD2	1.46±0.32	1.41±0.28	0.118		1.12±0.26	1.09±0.18	0.208
POD3	1.71±0.52	1.68±0.38	0.536		1.34±0.43	1.29±0.27	0.192

Data are presented as mean ± SD. PVB: paravertebral block using conventional epidural catheter; MPVB, paravertebral block using modified PVB catheter; POD, postoperative day.

Table 3

Arterial blood gas analysis in both groups

Variables	pH	PaCO2 (mmHg)	PaO2 (mmHg)
Pre-operation
MPVB	7.40±0.03	37.43±5.12	95.54±10.76
PVB	7.39±0.02	38.03±5.47	97.82±11.37
POD1
MPVB	7.38±0.04	38.84±7.89	98.45±13.25
PVB	7.36±0.05	39.11±6.86	95.64±12.43
POD2
MPVB	7.41±0.03	38.14±4.47	97.32±11.48
PVB	7.38±0.04	39.87±6.29	95.19±10.76
POD3
MPVB	7.43±0.05	37.76±4.65	94.56±11.33
PVB	7.40±0.06	39.34±3.89	94.39±10.45

Data are presented as mean ± SD. PVB, paravertebral block using conventional epidural catheter; MPVB, paravertebral block using modified PVB catheter; POD, postoperative day.

Table 4

Perioperative clinical outcomes

Variables	MPVB group (n=182)	PVB group (n=174)	P value
Analgesia-related adverse events
Respiratory depression	0	0
Nausea and vomiting	6 (3.3%)	5 (2.9%)	0.818
Hypotension	2 (1.1%)	4 (2.3%)	0.440
Urinary retention	1 (0.5%)	4 (2.3%)	0.206
Headache	1 (0.5%)	2 (1.1%)
Characteristics of PVB procedure			0.616
Pleural perforation	4 (2.2%)	13 (7.5%)	0.020
Hematoma under parietal pleura	6 (3.3%)	11 (6.3%)	0.181
Consumption of drugs in pump (mL)	130.29±48.25	117.14±52.82	0.015
Postoperative data
ICU duration of stay (d)	1.08±0.58	1.25±1.10	0.067
Chest tube indwelling time (d)	2.14±1.60	2.39±1.82	0.169
Hospital stay duration (d)	4.19±2.53	4.48±3.14	0.337
Major operative complications
Pneumonia	9 (4.9%)	11 (6.3%)	0.573
Atelectasis	6 (3.3%)	4 (2.3%)	0.751
Chylothorax	1 (0.5%)	2 (1.1%)	0.616
Pulmonary embolism	0 (0%)	1 (0.6%)	0.489
Reoperation	1 (0.5%)	3 (1.7%)	0.362

Data are presented as mean ± SD or n (%). POD, postoperative day.

Discussion

In our study, we aimed to assess the efficacy and safety of paravertebral block with a modified catheter under surgeon’s direct vision after VATS lobectomy. VATS lobectomy was first introduced in 1992 (17), since which it has been increasingly performed as an alternative to thoracotomy due to the minimally invasive nature of the procedure and its many superiorities (2). However, acute pain after VATS could still be severe, with potential to evolve into chronic pain (16).

Continuous epidural thoracic anesthesia was considered as the gold standard of analgesia after thoracotomy and also routinely used after VATS in some centers (18,19), but the results of meta-analyze and other studies have demonstrated that paravertebral block can substantially enhance pain management for thoracoscopic surgery and have a better profile of safety than epidural block, which is particularly visible in the lower incidences of hypotension and urinary retention (11,20). Paravertebral block, introduced by Eason et al. (21), is a regional block technique. In recent years, it has been gradually developing as an alternative pain management after surgeries. Paravertebral blocks are implemented with several approaches, varying from a percutaneous needle below or above the transverse vertebral process for single shot or prolonged catheter infusion to visually guided placement of a catheter during surgery (22). Currently, there is no clear united standard for procedures of PVB in patients undergoing VATS. Some authors believe that paravertebral block using the classical landmark puncture technique might be controlled in single injection technique, but was unstable for the continuous block (13). Despite the methods of identification by ultrasound-guide, the final location of paravertebral catheters is still the major issue (14,15). In a number of centers, advancement of the needle and insertion of the catheter were verified continuously by the surgeon using the camera (16,23), and this measure was also performed in this study. Though some authors believed that start PVB before skin incision tended to show better pain control in thoracotomy (24), we supposed that start PVB upon completion of the VATS could achieve similar effect because the operation of VATS was minimally invasive, and this measure has been reported in several studies (16,23,25). Furthermore, the device which could be specifically used for PVB after VATS has not been reported so far, and the device used in other studies is conflicting, especially for the paravertebral catheter. Wu et al. (23) reported new forceps used for catheterization and the conventional epidural catheter (19G; Pajunk GmbH Medizintechnologie, Germany) was placed in the paravertebral space as the paravertebral catheter. Komatsu et al. (26) also used a commercially available 18-gauge epidural catheter as indwelling extrapleural catheter, while 82 of the 278 patients (29.5%) met pleural disruption during PVB catheterization in their report. In this study, though the similar Tuohy needle was used in both groups, the modified catheter applied in MPVB group had a flexible forepart and several pores were distributed on the hemispherical tip of the catheter, which may contribute to the lower incidence of pleural perforation in the MPVB group than that in the PVB group.

The use of a PVB catheter placed by the surgeons for continuous infusion of local analgesia was demonstrated to be as effective as the epidural block for thoracic surgery (27,28). However, the effect of continuous analgesia of PVB is related to the location of paravertebral catheter and the diffusion of analgesic drugs among the paravertebral space. Theoretically, the paravertebral pump in this study could provide approximately 2 mL/h infusion of drugs to the paravertebral space if the channel was unobstructed. However, we found substantial analgesia residue left when the pumps were removed in patients undergoing PVB with conventional epidural catheter, which may reflect inadequate local analgesic. After application of the modified catheter, the consumption of mixture in the pump of MPVB group was larger than that in the pump of PVB group, which might show a better infusion of drags through the modified catheter. The modified paravertebral catheter had 6-cm flexible forepart coiled beneath the pleura and more apertures were distributed tightly along the forepart than the conventional epidural catheter, which may contribute to the diffusion of drugs into the paravertebral space in the MPVB group. As shown in other researches, larger number of dermatome inhibition could increase more analgesia efficacy (16). In this study, the mean VAS score at 12 h after surgery during coughing states was significant lower in the MPVB group than that in the PVB group, and the mean VAS score at 24 h after surgery during rest or coughing states were both lower in the MPVB group than those in the PVB group. Furthermore, the number of patients who need for rescue medication before the pump removed was also significantly lower in MPVB group, which also revealed a better pain management effect of PVB with modified catheter. However, if drugs from the pump were too much, it may enter epidural space and increase the risk of adverse reactions. Giang et al. (16) reported a patient-controlled analgesia device (Perfusor Space; B/Braun) which was programmed to provide a continuous infusion at 3 mL/h and to permit a 2 mL of demand bolus with a 10-minute lockout interval, limited to 25 mL over 4 hours. We supposed that the patient-controlled analgesia device could be added to the modified catheter in our further investigation.

The thoracic epidural block was also routinely used after VATS, but several studies demonstrated that patients who applied epidural block may accomplished with more side effects than the patients who applied paravertebral block after VATS (11). In this study, no patients in either group suffered respiratory depression. Though a few of patients in both groups suffered other analgesia-related adverse events, the incidence was low and there was no significant difference between the two groups. What’s more, thoracic surgery has the potential to severely compromise respiratory mechanics and gas exchange, which may delay the recovery of patients and result in prolonged postoperative hospital stay (29,30). In this study, we assessed spirometry results and arterial blood gas analysis to evaluate pulmonary function. In both groups, FVC and FEV1 had decreased significantly on POD1 compared to baseline values and recovered from POD1 to POD3. There was no significant difference of FVC and FEV1 between the two groups on POD1-3. Arterial blood gas analysis showed normal ranges of both pH and PaCO2 in two groups after surgery. PaO2 may have lower reference value because it depends on oxygen support to some degree. In this study, the incidence of pulmonary complications including pneumonia and atelectasis were comparable between the two groups, and there is no significant difference between the two groups in terms of other major complications such as chylothorax, pulmonary embolism and reoperation.

Recently, the serratus plane block and other regional blocks have been widely applied in VATS. Wang et al. (31) performed serratus plane block and thoracic paravertebral block on patients after uniportal video-assisted thoracoscopic surgery and they demonstrated comparable postoperative pain management effect between the two approaches. However, PVB with modified catheter performed in this study was conducted upon the completion of surgery, and its pain management effect compared with other regional blocks such as serratus plane block or epidural block remains to be further explored.

Conclusions

PVB with the modified catheter under surgeon’s direct vision could provide better regional analgesic effect, comparable respiratory function and analgesia-related adverse events, and lower incidence of pleural perforation than PVB with the conventional epidural catheter. We demonstrated that PVB with the modified catheter under surgeon’s direct vision might be considered as a safe and effective approach for pain management after video-assisted thoracoscopic lobectomy.

Limitation

The VAS scores were evaluated in our study. However, patients’ satisfaction and life quality were not mentioned, which could cause insufficient evidence to reflect patients’ subjective feeling. Meanwhile, we are preparing for a new randomized controlled trial (RCT) to compare the safety and efficacy between modified catheter and conventional epidural catheter for PVB.

The article’s supplementary files as